| Product Code: ETC7651262 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Failed Back Surgery Syndrome Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Failed Back Surgery Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Failed Back Surgery Syndrome Market - Industry Life Cycle |
3.4 Israel Failed Back Surgery Syndrome Market - Porter's Five Forces |
3.5 Israel Failed Back Surgery Syndrome Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Israel Failed Back Surgery Syndrome Market Revenues & Volume Share, By Late-Stage Pipeline Drugs, 2021 & 2031F |
4 Israel Failed Back Surgery Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of failed back surgery syndrome in Israel |
4.2.2 Growing adoption of minimally invasive spine surgeries |
4.2.3 Advancements in surgical techniques and technologies for treating failed back surgery syndrome |
4.3 Market Restraints |
4.3.1 High costs associated with revision surgeries for failed back surgery syndrome |
4.3.2 Limited healthcare reimbursement for certain treatments |
4.3.3 Lack of skilled healthcare professionals specializing in failed back surgery syndrome management |
5 Israel Failed Back Surgery Syndrome Market Trends |
6 Israel Failed Back Surgery Syndrome Market, By Types |
6.1 Israel Failed Back Surgery Syndrome Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Drug Overview, 2021- 2031F |
6.1.4 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Mechanism of Action, 2021- 2031F |
6.1.5 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Regulatory Status, 2021- 2031F |
6.1.6 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Clinical Trial Results, 2021- 2031F |
6.1.7 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Drug Uptake and Market Performance, 2021- 2031F |
6.2 Israel Failed Back Surgery Syndrome Market, By Late-Stage Pipeline Drugs |
6.2.1 Overview and Analysis |
6.2.2 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Drug Overview, 2021- 2031F |
6.2.3 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Mechanism of Action, 2021- 2031F |
6.2.4 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Regulatory Status, 2021- 2031F |
6.2.5 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Clinical Trial Results, 2021- 2031F |
6.2.6 Israel Failed Back Surgery Syndrome Market Revenues & Volume, By Drug Uptake and Market Performance, 2021- 2031F |
7 Israel Failed Back Surgery Syndrome Market Import-Export Trade Statistics |
7.1 Israel Failed Back Surgery Syndrome Market Export to Major Countries |
7.2 Israel Failed Back Surgery Syndrome Market Imports from Major Countries |
8 Israel Failed Back Surgery Syndrome Market Key Performance Indicators |
8.1 Average length of hospital stay for patients undergoing revision surgeries |
8.2 Number of medical conferences or training programs focusing on failed back surgery syndrome in Israel |
8.3 Patient satisfaction rates post-revision surgery |
8.4 Adoption rate of new surgical technologies for treating failed back surgery syndrome |
8.5 Percentage of patients opting for non-surgical treatment modalities post-failed back surgery |
9 Israel Failed Back Surgery Syndrome Market - Opportunity Assessment |
9.1 Israel Failed Back Surgery Syndrome Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Israel Failed Back Surgery Syndrome Market Opportunity Assessment, By Late-Stage Pipeline Drugs, 2021 & 2031F |
10 Israel Failed Back Surgery Syndrome Market - Competitive Landscape |
10.1 Israel Failed Back Surgery Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Israel Failed Back Surgery Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here